slotkoers
Korea S.E.
00:00:00 03-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
2.515
KRW
|
-1,57%
|
|
-5,98%
|
+5,01%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
453.984
|
169.714
|
196.458
|
124.057
|
109.830
|
133.971
|
Bedrijfswaarde
1 |
432.721
|
152.424
|
176.683
|
81.515
|
86.521
|
110.220
|
K/w-verhouding
|
-29,3
x
|
-6,89
x
|
-9,55
x
|
-4,27
x
|
-5,43
x
|
-4,43
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
49,5
x
|
28,3
x
|
21,5
x
|
10
x
|
6,74
x
|
10,5
x
|
Bedrijfswaarde/omzet
|
47,2
x
|
25,4
x
|
19,3
x
|
6,57
x
|
5,31
x
|
8,68
x
|
Bedrijfswaarde/EBITDA
|
-41,4
x
|
-7,24
x
|
-11,2
x
|
-4,32
x
|
-5,18
x
|
-5,84
x
|
Bedrijfswaarde/FCF
|
-37,3
x
|
-6,03
x
|
-16,5
x
|
-5,33
x
|
-6,36
x
|
-11
x
|
FCF Yield
|
-2,68%
|
-16,6%
|
-6,07%
|
-18,7%
|
-15,7%
|
-9,06%
|
Price to Book
|
9,52
x
|
2,46
x
|
3,83
x
|
1,82
x
|
2,23
x
|
2,79
x
|
Aantal aandelen (in duizenden)
|
20.825
|
20.849
|
24.837
|
37.938
|
37.938
|
55.938
|
Referentieprijs
2 |
21.800
|
8.140
|
7.910
|
3.270
|
2.895
|
2.395
|
Datum van publicatie
|
13-03-19
|
17-03-20
|
17-03-21
|
16-03-22
|
15-03-23
|
13-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
9.165
|
6.005
|
9.138
|
12.405
|
16.301
|
12.704
|
EBITDA
1 |
-10.457
|
-21.056
|
-15.732
|
-18.862
|
-16.688
|
-18.862
|
Bedrijfsresultaat (EBIT)
1 |
-11.694
|
-23.154
|
-18.725
|
-22.736
|
-20.558
|
-22.777
|
Operationele Marge
|
-127,59%
|
-385,6%
|
-204,92%
|
-183,28%
|
-126,12%
|
-179,29%
|
Resultaat voor belastingen (EBT)
1 |
-14.063
|
-26.302
|
-19.756
|
-21.811
|
-20.215
|
-23.137
|
Nettowinst (verlies)
1 |
-13.648
|
-24.635
|
-18.471
|
-21.348
|
-20.236
|
-21.949
|
Nettomarge
|
-148,91%
|
-410,26%
|
-202,14%
|
-172,1%
|
-124,14%
|
-172,77%
|
WPA
2 |
-744,7
|
-1.182
|
-828,4
|
-766,6
|
-533,4
|
-540,6
|
Free Cash Flow
1 |
-11.590
|
-25.257
|
-10.731
|
-15.281
|
-13.595
|
-9.991
|
FCF-marge
|
-126,45%
|
-420,62%
|
-117,43%
|
-123,19%
|
-83,4%
|
-78,64%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
13-03-19
|
17-03-20
|
17-03-21
|
16-03-22
|
15-03-23
|
13-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
21.262
|
17.291
|
19.775
|
42.542
|
23.309
|
23.751
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-11.590
|
-25.257
|
-10.731
|
-15.281
|
-13.595
|
-9.991
|
ROE (netto-inkomsten/eigen vermogen)
|
-40,3%
|
-45,4%
|
-33,7%
|
-36,4%
|
-32,5%
|
-45,2%
|
ROA (netto-inkomsten/totale activa)
|
-12,3%
|
-15,5%
|
-11,9%
|
-15,3%
|
-14%
|
-17,6%
|
Totale activa
1 |
111.211
|
159.030
|
154.791
|
139.460
|
144.687
|
124.768
|
Nettoactief per aandeel
2 |
2.290
|
3.314
|
2.067
|
1.793
|
1.300
|
858,0
|
Cashflow per aandeel
2 |
155,0
|
368,0
|
401,0
|
199,0
|
123,0
|
105,0
|
Capex
1 |
1.608
|
15.342
|
3.038
|
4.631
|
712
|
1.392
|
Capex/omzet
|
17,55%
|
255,51%
|
33,25%
|
37,33%
|
4,37%
|
10,96%
|
Datum van publicatie
|
13-03-19
|
17-03-20
|
17-03-21
|
16-03-22
|
15-03-23
|
13-03-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +5,01% | 104 mln. | | +25,69% | 47,86 mld. | | +46,90% | 41,42 mld. | | -3,46% | 40,66 mld. | | -6,20% | 28,92 mld. | | +9,17% | 25,55 mld. | | -20,42% | 19,27 mld. | | +0,17% | 12,15 mld. | | +28,07% | 12,14 mld. | | -1,24% | 11,99 mld. |
Biotechnologie & Medisch Onderzoek - Andere
|